( click to enlarge )
TrovaGene Inc (NASDAQ:TROV) surged 46c, or 28.22%, Friday on higher-than-average volume and finished at its highest close in more than four weeks. It closed at 2.09, substantially above key resistance at 1.79, confirming the breakout. The close was also near the high of the day, another good sign and indication of possible continuation of current momentum. Please note, the company announced last week that new clinical data from its Phase 2 trial of onvansertib, in combination with Zytiga® (abiraterone acetate)/prednisone, in metastatic Castration-Resistant Prostate Cancer (mCRPC), will be presented as an oral poster at the 20th Asia-Pacific Prostate Cancer Conference, which will be held August 23-26 in Melbourne, Australia. Lets see if we can see a rally like in March. Technically, the stock is now in Breakout mode.
( click to enlarge )
vTv Therapeutics Inc (NASDAQ: VTVT) has found support around the $1.23-$1.25 range again and looks poised to post a bounce from here. We could see a 20-30% possible bounce up to $1.95 - $2.25 a share if it can cross the resistance at $1.41 in the coming week. The recent insider buying of 1.2 million shares at $1.65 per share is also another positive indication that the insider are now bullish about the company.
( click to enlarge )
Stamps (NASDAQ: STMP) this is a stock that is still flying under the radar of so many traders and has been performing nicely recently. It needs to take out 64.16 (EMA100) next week in order to convince more bullish buyers at these levels.
( click to enlarge )
Celldex Therapeutics, Inc (NASDAQ: CLDX) After a strong decline since February highs, the stock is forming a base and on lower time frame it has started to form higher high and higher low which is a very positive sign. It might attempt to breakout above $2.3 level again next week and if it succeed we should expect a strong move to the upside.
( click to enlarge )
Air Products (NYSE: APD) Looking at the daily chart, the stock seems to be forming a Flag Pattern. It may gain the momentum once it manages to break 232.47 levels. Long setup on watch.
( click to enlarge )
Pfizer (NYSE: PFE) After the recent "crash" from the highs of 44.15 to 33.97, this stock appears to have hit a bottom around 34 as it is more or less trading flat for last three trading sessions. Hence, on a bounce back, the stock can easily test its declining 13-day EMA on the way upside. Swing traders can create fresh longs with a stop below 33.97 on closing basis for a short-term target of 36.5
( click to enlarge )
Microsoft (NASDAQ: MSFT) The recent correction from the highs of 141.2 brought it down towards its critical support of 132.5 levels (uptrend line) from where it rightly bounced back in Thursday’s session. Sustaining above this key support level, on a pullback, this stock can be expected to test its 140 level again next week or even making new highs. Long setup on watch.
( click to enlarge )
Obalon Therapeutics Inc (NASDAQ:OBLN) just hit its all time low while MACD Hist is displaying a positive divergence and looks to be starting what I think will be an impressive run off its bottom. Is this the short-term bottom? That is the risk, it could fall further, but I think we see a PSTV type move off these lows.
( click to enlarge )
Guardion Health Sciences Inc (NASDAQ: GHSI) some of you may recall many of my recent bottom calls, the best being RKDA at $2.5 it hit $9.15 a share. I think GHSI will have a relief rally after its dramatic fall. The stock has held its current range on the hourly chart meaning we could be seeing at least a temporary bottom. I wouldn't be surprised if this stock popped 20-25% in one session soon. We have a nice gap to fill. Note: Company Closed $5.8 Million Underwritten Public Offering on 15th August.
( click to enlarge )
FuelCell Energy Inc (NASDAQ: FCEL) volume is starting to come back and with it some positive price movement. With the continued growth in interest, the stock should see 45c and better short term.
( click to enlarge )
aTyr Pharma Inc (NASDAQ: LIFE) is a stock that is still flying under the radar of so many traders. I think right now LIFE is forming a solid base for a substantial move higher. Company has a strong cash position and good pipeline.
( click to enlarge )
Capricor Therapeutics Inc (NASDAQ:CAPR) suggest you keep this stock on your radar next week. At some point I think it will post an impressive rally. Chart speaks for itself.
During the day I tweet many times to my readers. I encourage everybody to subscribe AC Investor Blog twitter and newsletter, so you can receive my trade ideas and stock news in real time.
Disclaimer : This is not an investment advisory, and should not be used to make investment decisions. Information in AC Investor Blog is often opinionated and should be considered for information purposes only. No stock exchange anywhere has approved or disapproved of the information contained herein. There is no express or implied solicitation to buy or sell securities. The charts provided here are not meant for investment purposes and only serve as technical examples. Don't consider buying or selling any stock without conducting your own due diligence.
Thanks for visiting AC Investor Blog.
AC
Labels: APD, CAPR, CLDX, FCEL, GHSI, LIFE, MSFT, OBLN, PFE, STMP, TROV, VTVT